NCT05417334 Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
| NCT ID | NCT05417334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Clinic of Barcelona |
| Condition | Dyspareunia |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2021-03-18 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2021-03-18 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.
Eligibility Criteria
Inclusion Criteria: * 4-9 postpartum * de novo dyspareunia after delivery * obstetric injury * Grant informed consent Exclusion Criteria: * radiofrequency contraindications (pacemaker, active infection or pregnancy) * cesarean section * dyspareunia previous to labour * previous vulvo-vaginal pathology * patients with postpartum depression * patients with a pelvic region oncological history
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05417334 clinical trial?
This trial is open to female participants only, studying Dyspareunia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05417334 currently recruiting?
Yes, NCT05417334 is actively recruiting participants. Contact the research team at cebox@clinic.cat for enrollment information.
Where is the NCT05417334 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT05417334 clinical trial?
NCT05417334 is sponsored by Hospital Clinic of Barcelona. The trial plans to enroll 110 participants.